tiprankstipranks
Trending News
More News >
Anixa Biosciences (ANIX)
NASDAQ:ANIX
US Market

Anixa Biosciences (ANIX) Income Statement

Compare
502 Followers

Anixa Biosciences Income Statement

Last quarter (Q3 2025), Anixa Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Anixa Biosciences's net income was $0.00. See Anixa Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 210.00K$ 2.47B$ 512.50K$ 0.00
Gross Profit
$ -37.00K$ 49.00K$ 2.47B$ 127.50K$ -90.16K
Operating Expenses
$ 13.83M$ 11.06M$ 13.88M$ 13.26M$ 9.98M
Depreciation and Amortization
$ 37.00K$ 46.00K$ 42.00K$ 59.86K$ 90.16K
EBITDA
$ -12.66M$ -10.96M$ -13.73M$ -13.08M$ -10.00M
Operating Income
$ -13.83M$ -11.01M$ -13.88M$ -13.14M$ -9.98M
Other Income/Expenses
$ 1.13M$ 1.08M$ 104.00K$ -173.60K$ -114.16K
Pretax Income
$ -12.70M$ -9.93M$ -13.77M$ -13.31M$ -10.09M
Net Income
$ -12.55M$ -9.81M$ -13.49M$ -12.95M$ -10.13M
Per Share Metrics
Basic EPS
$ -0.39$ -0.32$ -0.44$ -0.45$ -0.46
Diluted EPS
$ -0.39$ -0.32$ -0.44$ -0.45$ -0.46
Weighted Average Shares Outstanding
31.90M 30.98M 30.37M 28.58M 22.23M
Weighted Average Shares Outstanding (Diluted)
31.90M 30.98M 30.37M 28.58M 22.23M
Currency in USD

Anixa Biosciences Earnings and Revenue History